These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8648738)

  • 1. Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.
    Bérubé P; Barbeau B; Cantin R; Sékaly RP; Tremblay M
    J Virol; 1996 Jun; 70(6):4009-16. PubMed ID: 8648738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.
    Briant L; Robert-Hebmann V; Acquaviva C; Pelchen-Matthews A; Marsh M; Devaux C
    J Virol; 1998 Jul; 72(7):6207-14. PubMed ID: 9621091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway.
    Popik W; Pitha PM
    Mol Cell Biol; 1996 Nov; 16(11):6532-41. PubMed ID: 8887682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 envelope protein does not stimulate either prostaglandin formation or the expression of prostaglandin H synthase in THP-1 human monocytes/macrophages.
    Hui R; Curtis JF; Sumner MT; Shears SB; Glasgow WC; Eling TE
    J Virol; 1995 Dec; 69(12):8020-6. PubMed ID: 7494315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
    Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H; Tarnok J; Parks WP
    J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
    Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
    AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.
    Golding H; Dimitrov DS; Manischewitz J; Broder CC; Robinson J; Fabian S; Littman DR; Lapham CK
    J Virol; 1995 Oct; 69(10):6140-8. PubMed ID: 7545243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Curr HIV Res; 2007 Jan; 5(1):79-86. PubMed ID: 17266559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.
    Popik W; Hesselgesser JE; Pitha PM
    J Virol; 1998 Aug; 72(8):6406-13. PubMed ID: 9658081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4.
    Briant L; Signoret N; Gaubin M; Robert-Hebmann V; Zhang X; Murali R; Greene MI; Piatier-Tonneau D; Devaux C
    J Biol Chem; 1997 Aug; 272(31):19441-50. PubMed ID: 9235945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
    Jenkinson S; McCoy DC; Kerner SA; Ferris RG; Lawrence WK; Clay WC; Condreay JP; Smith CD
    J Biomol Screen; 2003 Aug; 8(4):463-70. PubMed ID: 14567799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines.
    Greenway A; Azad A; McPhee D
    J Virol; 1995 Mar; 69(3):1842-50. PubMed ID: 7853525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of HIV-1 LTR during antigen-dependent activation of primary T cells by dendritic cells.
    Tsunetsugu-Yokota Y; Kato T; Yasuda S; Matsuda Z; Suzuki Y; Koyanagi Y; Yamamoto N; Akagawa K; Cho MW; Takemori T
    J Leukoc Biol; 2000 Mar; 67(3):432-40. PubMed ID: 10733105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in T lymphocytes requires CD4-gp120 binding.
    Marcuzzi A; Lowy I; Weinberger OK
    J Virol; 1992 Jul; 66(7):4536-9. PubMed ID: 1351104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells.
    Tamma SM; Kalyanaraman VS; Pahwa S; Dominguez P; Modesto RR
    J Leukoc Biol; 2003 May; 73(5):682-8. PubMed ID: 12714584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.